Home Services Industry Services Press Releases About Us Blogs Report Store Contact us

Animal Vaccine Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030

Published : Oct 2022

Report ID: ARC2793

Pages : 250

Format : Animal Vaccine Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030

CHAPTER 1. Industry Overview of Animal Vaccine Market

1.1. Definition and Scope

1.1.1. Definition of Animal Vaccine

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Animal Vaccine Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Animal Vaccine Market By Product

1.2.3. Animal Vaccine Market By Animal Type

1.2.4. Animal Vaccine Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Animal Vaccine Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Animal Vaccine Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Regulatory Compliance

3.9. Competitive Landscape, 2021

3.9.1. Player Positioning Analysis

3.9.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Animal Vaccine Market By Product

4.1. Introduction

4.2. Animal Vaccine Revenue By Product

4.2.1. Animal Vaccine Revenue (USD Million) and Forecast, By Product, 2018-2030

4.2.2. Attenuated Live Vaccines

4.2.2.1. Attenuated Live Vaccines Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.3. Inactivated Vaccines

4.2.3.1. Inactivated Vaccines Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.4. DNA Vaccines

4.2.4.1. DNA Vaccines Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.5. Subunit Vaccines

4.2.5.1. Subunit Vaccines Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.6. Recombinant Vaccines

4.2.6.1. Recombinant Vaccines Market Revenue (USD Million) and Growth Rate (%), 2018-2030

CHAPTER 5. Animal Vaccine Market By Animal Type

5.1. Introduction

5.2. Animal Vaccine Revenue By Animal Type

5.2.1. Animal Vaccine Revenue (USD Million) and Forecast, By Animal Type, 2018-2030

5.2.2. Poultry

5.2.2.1. Poultry Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.3. Companion

5.2.3.1. Companion Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.4. Aqua

5.2.4.1. Aqua Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.5. Ruminants

5.2.5.1. Ruminants Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.6. Swine

5.2.6.1. Swine Market Revenue (USD Million) and Growth Rate (%), 2018-2030

CHAPTER 6. North America Animal Vaccine Market By Country 

6.1. North America Animal Vaccine Market Overview

6.2. U.S.

6.2.1. U.S. Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030

6.2.2. U.S. Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030

6.3. Canada

6.3.1. Canada Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030

6.3.2. Canada Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030

6.4. North America PEST Analysis

CHAPTER 7. Europe Animal Vaccine Market By Country

7.1. Europe Animal Vaccine Market Overview

7.2. U.K.

7.2.1. U.K. Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030

7.2.2. U.K. Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030

7.3. Germany

7.3.1. Germany Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030

7.3.2. Germany Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030

France

7.3.3. France Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030

7.3.4. France Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030

7.4. Spain

7.4.1. Spain Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030

7.4.2. Spain Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030

7.5. Rest of Europe

7.5.1. Rest of Europe Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030

7.5.2. Rest of Europe Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030

7.6. Europe PEST Analysis

CHAPTER 8. Asia Pacific Animal Vaccine Market By Country

8.1. Asia Pacific Animal Vaccine Market Overview

8.2. China

8.2.1. China Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030

8.2.2. China Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030

8.3. Japan

8.3.1. Japan Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030

8.3.2. Japan Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030

8.4. India

8.4.1. India Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030

8.4.2. India Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030

8.5. Australia

8.5.1. Australia Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030

8.5.2. Australia Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030

8.6. South Korea

8.6.1. South Korea Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030

8.6.2. South Korea Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030

8.7. Rest of Asia-Pacific

8.7.1. Rest of Asia-Pacific Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030

8.7.2. Rest of Asia-Pacific Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030

8.8. Asia Pacific PEST Analysis

CHAPTER 9. Latin America Animal Vaccine Market By Country

9.1. Latin America Animal Vaccine Market Overview

9.2. Brazil

9.2.1. Brazil Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030

9.2.2. Brazil Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030

9.3. Mexico

9.3.1. Mexico Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030

9.3.2. Mexico Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030

9.4. Rest of Latin America

9.4.1. Rest of Latin America Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030

9.4.2. Rest of Latin America Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030

9.5. Latin America PEST Analysis

CHAPTER 10. Middle East & Africa Animal Vaccine Market By Country 

10.1. Middle East & Africa Animal Vaccine Market Overview

10.2. GCC

10.2.1. GCC Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030

10.2.2. GCC Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030

10.3. South Africa

10.3.1. South Africa Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030

10.3.2. South Africa Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030

10.4. Rest of Middle East & Africa

10.4.1. Rest of Middle East & Africa Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030

10.4.2. Rest of Middle East & Africa Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030

10.5. Middle East & Africa PEST Analysis

CHAPTER 11. Player Analysis Of Animal Vaccine Market

11.1. Animal Vaccine Market Company Share Analysis

11.2. Competition Matrix

11.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

11.2.2. New Product Launches and Product Enhancements

11.2.3. Mergers And Acquisition In Global Animal Vaccine Market

11.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 12. Company Profile

12.1. Merck & Co., Inc.

12.1.1. Company Snapshot

12.1.2. Business Overview

12.1.3. Financial Overview

12.1.3.1. Revenue (USD Million), 2021

12.1.3.2. Merck & Co., Inc. 2021 Animal Vaccine Business Regional Distribution

12.1.4. Product/Service and Specification

12.1.5. Recent Developments & Business Strategy

12.2. Ceva

12.3. Boehringer Ingelheim International GmbH

12.4. Neogen Corporation

12.5. Intas Pharmaceuticals Ltd

12.6. Zoetis

12.7. Biogénesis Bagó

12.8. Pfizer Inc.

12.9. Elanco Animal Health

Frequently Asked Questions

What is the size of global animal vaccine market in 2021?

The estimated value of global animal vaccine market in 2021 was accounted to be USD 7,731 Million.

What is the CAGR of global animal vaccine market during forecast period of 2022 to 2030?

The projected CAGR animal vaccine market during the analysis period of 2022 to 2030 is 7.5%.

Which are the key players operating in the market?

The prominent players of the global animal vaccine market are Merck & Co., Inc., Ceva, Boehringer Ingelheim International GmbH, Neogen Corporation, Intas Pharmaceuticals Ltd, Zoetis, Biogénesis Bagó, Pfizer Inc., and Elanco Animal Health.

Which region held the dominating position in the global animal vaccine market?

North America held the dominating animal vaccine during the analysis period of 2022 to 2030.

Which region registered the fastest growing CAGR for the forecast period of 2022 to 2030?

Asia-Pacific region exhibited fastest growing CAGR for animal vaccine during the analysis period of 2022 to 2030.

What are the current trends and dynamics in the global animal vaccine market?

Increase in the frequency of animal disease, and rise in animal health spending drives the growth of global animal vaccine market.

By animal type segment, which sub-segment held the maximum share?

Based on animal type, poultry segment is expected to hold the maximum share of the animal vaccine market.

Select Licence Type

Single User

US$ 4500

Multi User

US$ 9000

Excel Datapack

US$ 2000

Why Acumen Research and Consulting

100%

Customer Satisfaction

24x7+

Availability - we are always there when you need us

200+

Fortune 50 Companies trust Acumen Research and Consulting

80%

of our reports are exclusive and first in the industry

100%

more data and analysis

1000+

reports published till date